Peak Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.89M Buy
+3,242
New +$3.31M 1.61% 13
2024
Q3
Sell
-3,684
Closed -$3.34M 86
2024
Q2
$3.34M Buy
3,684
+34
+0.9% +$27.2K 1.91% 11
2024
Q1
$2.84M Sell
3,650
-354
-9% -$252K 1.73% 25
2023
Q4
$2.33M Buy
+4,004
New +$2.34M 1.56% 30

Other funds holding LLY

Peak Financial Advisors's LLY Position: Q2 2026 in Review

Peak Financial Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 3,242 shares worth $3.89M. The stake represents 1.61% of the portfolio and ranks #13 among its holdings. This is a return to the name: Peak Financial Advisors previously reported a position in LLY as recently as Q2 2024.

Peak Financial Advisors first reported a position in LLY in Q4 2023 and has held it in 4 quarters since. 893 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Peak Financial Advisors held 3,242 shares of Eli Lilly worth $3.89M as of Q2 2026.
  • Eli Lilly was a new Peak Financial Advisors position in Q2 2026.
  • Eli Lilly made up 1.61% of Peak Financial Advisors's portfolio in Q2 2026, its #13 holding.
  • Peak Financial Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 4 quarters since.
  • 893 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Peak Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.